{"transactions":[{"id":1889758,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2023-05-17T14:48:48.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":1669,"price":192.36,"value":321048.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The Stock Options become exercisable upon the earlier of 5/15/2024 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":1669,"derivative":{"exercise_price":192.36,"exercise_date":"2024-05-15","expiration_date":"2033-05-15","underlying":"Common Stock","underlying_shares":1669},"source":{"system":"sec-edgar","filing":"0001127602-23-015854","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760223015854/form4.xml","form_type":"4"}},{"id":1889757,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-17T14:48:48.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":442,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The grant was made in lieu of director service fees for the term commencing May 9, 2023. The restricted stock units vest upon the earlier of 5/15/2023 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":65541,"source":{"system":"sec-edgar","filing":"0001127602-23-015854","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760223015854/form4.xml","form_type":"4"}},{"id":1889756,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-17T14:48:48.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":664,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The unvested restricted stock units vest upon the earlier of 5/15/2024 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":65099,"source":{"system":"sec-edgar","filing":"0001127602-23-015854","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760223015854/form4.xml","form_type":"4"}},{"id":2272430,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2022-05-13T16:41:22.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":1582,"price":222.31,"value":351694.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The Stock Options become exercisable upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":1582,"derivative":{"exercise_price":222.31,"exercise_date":"2023-05-11","expiration_date":"2032-05-11","underlying":"Common Stock","underlying_shares":1582},"source":{"system":"sec-edgar","filing":"0001127602-22-014444","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760222014444/form4.xml","form_type":"4"}},{"id":2272429,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-13T16:41:22.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":382,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The grant was made in lieu of director service fees for the term commencing May 10, 2022. The restricted stock units vest upon the earlier of 5/11/2023, or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":64435,"source":{"system":"sec-edgar","filing":"0001127602-22-014444","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760222014444/form4.xml","form_type":"4"}},{"id":2272428,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-13T16:41:22.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The unvested restricted stock units vest upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":64053,"source":{"system":"sec-edgar","filing":"0001127602-22-014444","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760222014444/form4.xml","form_type":"4"}},{"id":2721400,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2021-05-10T17:43:34.000Z","date":"2021-05-07","kind":"grant","acquired":true,"shares":1151,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The Stock Options become exercisable upon the earlier of 5/7/2022 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":1151,"derivative":{"exercise_price":342.55,"exercise_date":"2022-05-07","expiration_date":"2031-05-07","underlying":"Common Stock","underlying_shares":1151},"source":{"system":"sec-edgar","filing":"0001127602-21-016115","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760221016115/form4.xml","form_type":"4"}},{"id":2721399,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-10T17:43:34.000Z","date":"2021-05-07","kind":"grant","acquired":true,"shares":234,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The grant was made in lieu of director service fees for the term commencing May 5, 2021. The restricted stock units vest upon the earlier of 5/7/2021, or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":63478,"source":{"system":"sec-edgar","filing":"0001127602-21-016115","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760221016115/form4.xml","form_type":"4"}},{"id":2721398,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-10T17:43:34.000Z","date":"2021-05-07","kind":"grant","acquired":true,"shares":355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The unvested restricted stock units vest upon the earlier of 5/7/2022 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":63244,"source":{"system":"sec-edgar","filing":"0001127602-21-016115","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760221016115/form4.xml","form_type":"4"}},{"id":3153100,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2020-05-12T14:02:09.000Z","date":"2020-05-11","kind":"grant","acquired":true,"shares":2539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Options become exercisable upon the earlier of 5/11/2021 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":2539,"derivative":{"exercise_price":164.24,"exercise_date":"2021-05-11","expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":2539},"source":{"system":"sec-edgar","filing":"0001127602-20-016240","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760220016240/form4.xml","form_type":"4"}},{"id":3153099,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-05-12T14:02:09.000Z","date":"2020-05-11","kind":"grant","acquired":true,"shares":487,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The grant was made in lieu of director service fees for the term commencing May 6, 2020.  The restricted stock units vest upon the earlier of 5/11/2021, or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":62889,"source":{"system":"sec-edgar","filing":"0001127602-20-016240","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760220016240/form4.xml","form_type":"4"}},{"id":3153098,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-05-12T14:02:09.000Z","date":"2020-05-11","kind":"grant","acquired":true,"shares":741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The unvested restricted stock units vest upon the earlier of 5/11/2021 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":62402,"source":{"system":"sec-edgar","filing":"0001127602-20-016240","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760220016240/form4.xml","form_type":"4"}},{"id":3513856,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-05-23T20:18:53.000Z","date":"2019-05-22","kind":"grant","acquired":true,"shares":619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This grant was made in lieu of director service fees for the term commencing May 21, 2019.  The restricted stock units vest upon the earlier of 5/22/2020, or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":61661,"source":{"system":"sec-edgar","filing":"0001127602-19-019736","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760219019736/form4.xml","form_type":"4"}},{"id":3513855,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-05-23T20:18:53.000Z","date":"2019-05-22","kind":"grant","acquired":true,"shares":1882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of 1,882 unvested restricted stock units that vest upon the earlier of 5/22/2020, or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":61042,"source":{"system":"sec-edgar","filing":"0001127602-19-019736","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760219019736/form4.xml","form_type":"4"}},{"id":3933312,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-05-15T16:06:15.000Z","date":"2018-05-14","kind":"grant","acquired":true,"shares":699,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This grant was made in lieu of director service fees for the term commencing May 8, 2018.  The restricted stock units vest upon the earlier of 5/14/2019 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":59160,"source":{"system":"sec-edgar","filing":"0001127602-18-017515","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760218017515/form4.xml","form_type":"4"}},{"id":3933311,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-05-15T16:06:15.000Z","date":"2018-05-14","kind":"grant","acquired":true,"shares":2004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of 2,004 unvested restricted stock units that vest upon the earlier of 5/14/2019, or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":58461,"source":{"system":"sec-edgar","filing":"0001127602-18-017515","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760218017515/form4.xml","form_type":"4"}},{"id":4138173,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2017-12-08T10:06:54.000Z","date":"2017-12-06","kind":"exercise","acquired":false,"shares":3140,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":70.29,"exercise_date":"2016-05-06","expiration_date":"2020-05-06","underlying":"Common Stock","underlying_shares":3140},"source":{"system":"sec-edgar","filing":"0001127602-17-034175","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760217034175/form4.xml","form_type":"4"}},{"id":4138172,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2017-12-08T10:06:54.000Z","date":"2017-12-06","kind":"exercise","acquired":false,"shares":3530,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":52.29,"exercise_date":"2015-05-07","expiration_date":"2021-05-07","underlying":"Common Stock","underlying_shares":3530},"source":{"system":"sec-edgar","filing":"0001127602-17-034175","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760217034175/form4.xml","form_type":"4"}},{"id":4138171,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2017-12-08T10:06:54.000Z","date":"2017-12-06","kind":"exercise","acquired":false,"shares":4030,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":43.39,"exercise_date":"2014-05-08","expiration_date":"2020-05-08","underlying":"Common Stock","underlying_shares":4030},"source":{"system":"sec-edgar","filing":"0001127602-17-034175","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760217034175/form4.xml","form_type":"4"}},{"id":4138170,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2017-12-08T10:06:54.000Z","date":"2017-12-06","kind":"exercise","acquired":false,"shares":4540,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":33.93,"exercise_date":"2013-05-09","expiration_date":"2019-05-09","underlying":"Common Stock","underlying_shares":4540},"source":{"system":"sec-edgar","filing":"0001127602-17-034175","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760217034175/form4.xml","form_type":"4"}},{"id":4138169,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2017-12-08T10:06:54.000Z","date":"2017-12-06","kind":"exercise","acquired":false,"shares":7740,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":40.27,"exercise_date":"2012-05-11","expiration_date":"2018-05-11","underlying":"Common Stock","underlying_shares":7740},"source":{"system":"sec-edgar","filing":"0001127602-17-034175","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760217034175/form4.xml","form_type":"4"}},{"id":4138168,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-08T10:06:54.000Z","date":"2017-12-06","kind":"sale","acquired":false,"shares":10227,"price":102.4,"value":1047244.8,"ownership":{"direct":true},"balance_after":56457,"source":{"system":"sec-edgar","filing":"0001127602-17-034175","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760217034175/form4.xml","form_type":"4"}},{"id":4138167,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-08T10:06:54.000Z","date":"2017-12-06","kind":"exercise","acquired":true,"shares":3140,"price":70.29,"value":220710.6,"ownership":{"direct":true},"balance_after":66684,"source":{"system":"sec-edgar","filing":"0001127602-17-034175","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760217034175/form4.xml","form_type":"4"}},{"id":4138166,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-08T10:06:54.000Z","date":"2017-12-06","kind":"exercise","acquired":true,"shares":3530,"price":52.29,"value":184583.7,"ownership":{"direct":true},"balance_after":63544,"source":{"system":"sec-edgar","filing":"0001127602-17-034175","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760217034175/form4.xml","form_type":"4"}},{"id":4138165,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-08T10:06:54.000Z","date":"2017-12-06","kind":"exercise","acquired":true,"shares":4030,"price":43.39,"value":174861.7,"ownership":{"direct":true},"balance_after":60014,"source":{"system":"sec-edgar","filing":"0001127602-17-034175","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760217034175/form4.xml","form_type":"4"}},{"id":4138164,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-08T10:06:54.000Z","date":"2017-12-06","kind":"exercise","acquired":true,"shares":4540,"price":33.93,"value":154042.2,"ownership":{"direct":true},"balance_after":55984,"source":{"system":"sec-edgar","filing":"0001127602-17-034175","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760217034175/form4.xml","form_type":"4"}},{"id":4138163,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-08T10:06:54.000Z","date":"2017-12-06","kind":"exercise","acquired":true,"shares":7740,"price":40.27,"value":311689.8,"ownership":{"direct":true},"balance_after":51444,"source":{"system":"sec-edgar","filing":"0001127602-17-034175","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760217034175/form4.xml","form_type":"4"}},{"id":4321180,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-15T18:17:10.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This grant was made in lieu of director service fees for the term commencing May 9, 2017, and includes an increase to the fee he receives for being Chair of the Compensation Committee fee, which was effective at the beginning of 2017.  The restricted stock units vest upon the earlier of 5/12/2018, or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":43704,"source":{"system":"sec-edgar","filing":"0001127602-17-018148","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760217018148/form4.xml","form_type":"4"}},{"id":4321179,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-15T18:17:10.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":2436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of 2,436 unvested restricted stock units that vest upon the earlier of 5/12/2018, or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":42840,"source":{"system":"sec-edgar","filing":"0001127602-17-018148","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760217018148/form4.xml","form_type":"4"}},{"id":4540274,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2016-11-29T08:43:10.000Z","date":"2016-11-28","kind":"exercise","acquired":false,"shares":10710,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":30.44,"exercise_date":"2011-05-07","expiration_date":"2017-05-07","underlying":"Common Stock","underlying_shares":10710},"source":{"system":"sec-edgar","filing":"0001127602-16-068550","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760216068550/form4.xml","form_type":"4"}},{"id":4540273,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2016-11-29T08:43:10.000Z","date":"2016-11-28","kind":"sale","acquired":false,"shares":3988,"price":71.93,"value":286856.84,"ownership":{"direct":true},"balance_after":40404,"source":{"system":"sec-edgar","filing":"0001127602-16-068550","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760216068550/form4.xml","form_type":"4"}},{"id":4540272,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2016-11-29T08:43:10.000Z","date":"2016-11-28","kind":"sale","acquired":false,"shares":551,"price":71.92,"value":39627.92,"ownership":{"direct":true},"balance_after":44392,"source":{"system":"sec-edgar","filing":"0001127602-16-068550","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760216068550/form4.xml","form_type":"4"}},{"id":4540271,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":113419,"kind":"person","name":"REESE C RICHARD","position":1,"cik":"0001032365","reported_name":"REESE C RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2016-11-29T08:43:10.000Z","date":"2016-11-28","kind":"exercise","acquired":true,"shares":10710,"price":30.44,"value":326012.4,"ownership":{"direct":true},"balance_after":44943,"source":{"system":"sec-edgar","filing":"0001127602-16-068550","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1032365/000112760216068550/form4.xml","form_type":"4"}}]}